Cargando…
NMDA Receptor Model of Antipsychotic Drug-Induced Hypofrontality
Schizophrenia is a chronic mental disease, affecting around 1% of the general population. Schizophrenia is characterized by productive, negative, affective, and disorganization symptoms, and cognitive deficits. Cognitive deficits prevail in most of the schizophrenia patients and are one of the most...
Autores principales: | Krzystanek, Marek, Pałasz, Artur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471005/ https://www.ncbi.nlm.nih.gov/pubmed/30901926 http://dx.doi.org/10.3390/ijms20061442 |
Ejemplares similares
-
Spider Neurotoxins as Modulators of NMDA Receptor Signaling
por: Pałasz, Artur, et al.
Publicado: (2021) -
Selected single-nucleotide variants in GRIN1, GRIN2A, and GRIN2B encoding subunits of the NMDA receptor are not biomarkers of schizophrenia resistant to clozapine: exploratory study
por: Krzystanek, Marek, et al.
Publicado: (2020) -
Exploratory study of selected nucleotide variants in GRIN1, GRIN2A and GRIN2B encoding subunits of the NMDA receptor in a targeted group of schizophrenia patients with chronic cognitive impairment
por: Krzystanek, Marek, et al.
Publicado: (2020) -
Amantadine in the Treatment of Sexual Inactivity in Schizophrenia Patients Taking Atypical Antipsychotics—The Pilot Case Series Study
por: Krzystanek, Marek, et al.
Publicado: (2021) -
Antipsychotics increase steroidogenic enzyme gene expression in the rat brainstem
por: Bogus, Katarzyna, et al.
Publicado: (2021)